NIPER Raebareli and AstraZeneca to Expand Clinical Trials to 25 Emerging Hubs

Posted
NIPER Raebareli and AstraZeneca India have partnered to enhance clinical trial capabilities across 25 emerging research sites in India.

Continue reading at IB Times ยป